Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Saturday. The brokerage issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of Milestone Scientific stock opened at $0.88 on Friday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.10. The business has a 50-day moving average of $0.81 and a two-hundred day moving average of $0.86. The company has a market capitalization of $68.54 million, a P/E ratio of -12.57 and a beta of 1.10.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 24.75% of the stock is owned by company insiders.

Institutional Trading of Milestone Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MLSS. Y Intercept Hong Kong Ltd bought a new position in Milestone Scientific in the third quarter worth approximately $48,000. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific during the third quarter worth approximately $91,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares in the last quarter. 5.79% of the stock is owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.